These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 15916295)

  • 21. Proceedings of the 6th Novo Nordisk Symposium on Treatment of Bleeding and Thrombotic Disorders. Copenhagen, Denmark, May 3-4, 2001.
    Semin Hematol; 2001 Oct; 38(4 Suppl 12):1-50. PubMed ID: 11840984
    [No Abstract]   [Full Text] [Related]  

  • 22. Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
    Weiskopf RB
    Vox Sang; 2007 May; 92(4):281-8. PubMed ID: 17456151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coagulopathy: its pathophysiology and treatment in the injured patient.
    Tieu BH; Holcomb JB; Schreiber MA
    World J Surg; 2007 May; 31(5):1055-64. PubMed ID: 17426904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Updates in the management of severe coagulopathy in trauma patients.
    Lynn M; Jeroukhimov I; Klein Y; Martinowitz U
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S241-7. PubMed ID: 12404093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Damage control: collective review.
    Shapiro MB; Jenkins DH; Schwab CW; Rotondo MF
    J Trauma; 2000 Nov; 49(5):969-78. PubMed ID: 11086798
    [No Abstract]   [Full Text] [Related]  

  • 26. Coagulopathy and inflammation in neonatal heart surgery: mechanisms and strategies.
    Jaggers J; Lawson JH
    Ann Thorac Surg; 2006 Jun; 81(6):S2360-6. PubMed ID: 16731104
    [No Abstract]   [Full Text] [Related]  

  • 27. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: a retrospective comparative study.
    Roitberg B; Emechebe-Kennedy O; Amin-Hanjani S; Mucksavage J; Tesoro E
    Neurosurgery; 2005 Nov; 57(5):832-6; discussion 832-6. PubMed ID: 16284552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of recombinant activated factor VII in the control of haemorrhage following blunt pelvic trauma.
    Udy A; Vaghela M; Lawton G; Sigston P
    Anaesthesia; 2005 Jun; 60(6):613-6. PubMed ID: 15918835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ongoing NovoSeven trials.
    Erhardtsen E
    Intensive Care Med; 2002 Oct; 28 Suppl 2():S248-55. PubMed ID: 12404094
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseases.
    Mathew P; Winter SS; Frost JD; Hanrahan J; Schwartz M; Jones JE
    J Pediatr Hematol Oncol; 2003 Jun; 25(6):499-502. PubMed ID: 12794532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant activated factor VII for the treatment of life-threatening haemorrhage.
    Eikelboom JW; Bird R; Blythe D; Coyle L; Gan E; Harvey M; Isbister J; Leahy M; McIlroy D; Rahimpanah F; Ramanthan S; Strasser S; Ward C; Watts A; Towler S; Yi Q
    Blood Coagul Fibrinolysis; 2003 Dec; 14(8):713-7. PubMed ID: 14614349
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
    Dickneite G; Dörr B; Kaspereit F; Tanaka KA
    J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review.
    Mathew P
    Thromb Haemost; 2004 Oct; 92(4):738-46. PubMed ID: 15467904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of recombinant factor VIIa in liver diseases.
    Franchini M; Montagnana M; Targher G; Zaffanello M; Lippi G
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):341-8. PubMed ID: 18600080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
    Caldwell SH; Chang C; Macik BG
    Hepatology; 2004 Mar; 39(3):592-8. PubMed ID: 14999675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Recombinant activated factor VII used in a man with refractory bleeding from a stab wound injuring the liver and kidney].
    Arnal D; Piñeiro P; Garutti I; Olmedilla L; Sanz J; Lajara A
    Rev Esp Anestesiol Reanim; 2004 May; 51(5):284-8. PubMed ID: 15214766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effective management of refractory postcardiotomy bleeding with the use of recombinant activated factor VII.
    Filsoufi F; Castillo JG; Rahmanian PB; Scurlock C; Fischer G; Adams DH
    Ann Thorac Surg; 2006 Nov; 82(5):1779-83. PubMed ID: 17062247
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effective treatment of life-threatening bleeding with recombinant activated factor VII in a patient with acute promyelocytic leukaemia.
    Zver S; Andoljsek D; Cernelc P
    Eur J Haematol; 2004 Jun; 72(6):455-6. PubMed ID: 15128428
    [No Abstract]   [Full Text] [Related]  

  • 39. Use of recombinant activated factor VII in massive obstetric haemorrhage.
    Haynes J; Laffan M; Plaat F
    Int J Obstet Anesth; 2007 Jan; 16(1):40-9. PubMed ID: 17126006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current world literature. Trauma and transfusion.
    Curr Opin Anaesthesiol; 2009 Apr; 22(2):321-5. PubMed ID: 19399963
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.